Van Well Daan 4

What Happened

• Daan Van Well, Chief Legal Officer of SOPHiA GENETICS SA (SOPH), sold a total of 5,105 shares in two open-market transactions to satisfy tax withholding on vested restricted stock units. On 2026-04-06 he sold 2,705 shares at a weighted average price of $4.86 for proceeds of $13,136 (footnote F2). On 2026-04-07 he sold 2,400 shares at a weighted average price of $4.87 for proceeds of $11,682 (footnote F3). Total proceeds were approximately $24,818.

Key Details

• Transaction dates and reported prices:
  • 2026-04-06: 2,705 shares sold, weighted avg price $4.86 (individual prices ranged $4.685–$4.95) — $13,136 (F2).
  • 2026-04-07: 2,400 shares sold, weighted avg price $4.87 (individual prices ranged $4.77–$4.945) — $11,682 (F3).
• Purpose: Sales were to satisfy tax withholding obligations from RSU vestings on April 2 and 3, 2026 (footnote F1).
• Trading plan: Sales were effected pursuant to a pre-established Rule 10b5-1 plan and are described as non-discretionary (F1).
• Shares owned after the transactions: Not disclosed in the summary information provided.
• Filing timeliness: Form 4 was filed on 2026-04-08; based on the transaction dates (4/6 and 4/7) this appears to be a timely report.

Context

• These were routine, tax-withholding sales of vested RSUs under a 10b5-1 plan, not new purchases or directional bets. The insider has offered to provide, on request, a breakdown of how many shares were sold at each specific price within the reported ranges.